Suzuken Co., Ltd. (SZUKF)
USD 30.3
(0.0%)
USD 30.3
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.22 Billion USD | 3.09% |
| 2023 | 1.35 Billion USD | -1.61% |
| 2022 | 1.37 Billion USD | -3.77% |
| 2021 | 1.42 Billion USD | -20.56% |
| 2020 | 1.79 Billion USD | 5.14% |
| 2019 | 1.71 Billion USD | -3.0% |
| 2018 | 1.76 Billion USD | 1.68% |
| 2017 | 1.73 Billion USD | -3.74% |
| 2016 | 1.8 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 281.53 Million USD | -9.86% |
| 2024 FY | 1.22 Billion USD | -9.51% |
| 2024 Q3 | 338.8 Million USD | -4.74% |
| 2024 Q4 | 308.01 Million USD | -2.48% |
| 2024 Q2 | 335.83 Million USD | 23.5% |
| 2023 FY | 1.35 Billion USD | -1.61% |
| 2023 Q2 | 338.81 Million USD | 18.16% |
| 2023 Q1 | 286.73 Million USD | -20.31% |
| 2023 Q3 | 355.45 Million USD | 4.91% |
| 2023 Q4 | 339.31 Million USD | -4.54% |
| 2022 Q2 | 398.9 Million USD | 37.58% |
| 2022 FY | 1.37 Billion USD | -3.77% |
| 2022 Q4 | 359.8 Million USD | 2.0% |
| 2022 Q3 | 352.76 Million USD | -11.57% |
| 2022 Q1 | 289.93 Million USD | -19.73% |
| 2021 FY | 1.42 Billion USD | -20.56% |
| 2021 Q4 | 361.2 Million USD | 0.0% |
| 2020 FY | 1.79 Billion USD | 5.14% |
| 2019 FY | 1.71 Billion USD | -3.0% |
| 2018 FY | 1.76 Billion USD | 1.68% |
| 2017 FY | 1.73 Billion USD | -3.74% |
| 2016 FY | 1.8 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China Medicine Corporation | 18.98 Million USD | -6347.087% |
| DH Enchantment Inc. | -406.00 USD | 301463189.409% |
| Exlites Holdings International, Inc. | 18.74 Thousand USD | -6531064.05% |
| Itonis, Inc. | 1801.00 USD | -67958819.656% |
| One Step Vending Corp. | -1238.00 USD | 98864408.805% |
| MediPal Holdings Corporation | 1.53 Billion USD | 20.497% |
| PD-Rx Pharmaceuticals, Inc. | 6.71 Million USD | -18132.3% |
| Pharmagen, Inc. | 3045.21 USD | -40192206.705% |